Intelligent Oxygen Therapy During Activities of Daily Living
Primary Purpose
Hypoxia, COPD, Hyperoxia
Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Intelligent oxygen therapy (an auto-titrating oxygen system)
Long-term oxygen therapy
Sponsored by
About this trial
This is an interventional treatment trial for Hypoxia
Eligibility Criteria
Inclusion Criteria:
- Age >18 years
- Currently on or eligible for LTOT for respiratory failure
Exclusion Criteria:
- LTOT flow rate ≥4 litres per minute
- Exacerbation of underlying lung disease in the past 4 weeks
- Inability to understand English
- Significant co-morbidities
- Patients who lack capacity to consent
- Pregnancy
Sites / Locations
- Royal Brompton and Harefield NHS Trust
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Activities of daily living on iO2t
Activities of daily living on LTOT
Arm Description
Patients will complete simulated activities of daily living on intelligent oxygen therapy (an auto-titrating oxygen system)
Patients will complete activities of daily living on their usual long-term oxygen therapy.
Outcomes
Primary Outcome Measures
The percentage of time spent with SpO2 <90% during the activities of daily living - 55 minutes
Secondary Outcome Measures
Mean SpO2 during the activities of daily living - 55 minutes
Mean Heart rate during the activities of daily living - 55 minutes
Borg score for breathlessness and fatigue at the end of activities of daily living (55 minutes)
Total volume of oxygen delivered during simulated activities of daily living during the activities of daily living (55 minutes)
Full Information
NCT ID
NCT02683486
First Posted
January 26, 2016
Last Updated
October 5, 2021
Sponsor
Imperial College London
Collaborators
National Institute for Health Research, United Kingdom, Royal Brompton & Harefield NHS Foundation Trust
1. Study Identification
Unique Protocol Identification Number
NCT02683486
Brief Title
Intelligent Oxygen Therapy During Activities of Daily Living
Official Title
The Assessment of Intelligent Oxygen Therapy (iO2T) in Patients on Long-term Oxygen Therapy During Activities of Daily Living
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
January 2016 (Actual)
Primary Completion Date
January 1, 2017 (Actual)
Study Completion Date
January 15, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Imperial College London
Collaborators
National Institute for Health Research, United Kingdom, Royal Brompton & Harefield NHS Foundation Trust
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to assess whether an auto-titrating oxygen system can maintain constant oxygen saturations (SpO2) in patients who are on long-term oxygen therapy (LTOT) during activities of daily living.
Currently LTOT is provided at a constant fixed-flow rate e.g. 2 litres per minute all the time after appropriate assessment. The flow rate is not changed during usual household activities but is increased for walking. A number of studies have investigated the SpO2 of patients on LTOT during the daytime in patients' homes. The results have shown that patients' SpO2 decreases intermittently whilst they are doing activities of daily living such as watching television, putting away the shopping, having a shower or bath and dressing and undressing. This is a problem as it can lead to breathlessness, increased stress on the heart and affect brain function. In order to correct the drop in SpO2 that patients experience during everyday activities, the investigators have developed an oxygen system, which can automatically change the amount of oxygen delivered depending on a patients' oxygen saturations - an auto-titrating oxygen system. In this study, patients on LTOT will be asked to simulate a series of activities of daily living twice: once whilst on their usual fixed-flow oxygen therapy and once on the auto-titrating oxygen system. The activities will be carried out in a hospital setting. During the activities, SpO2 will be recorded continuously. The main outcome of interest from the study will be the SpO2 throughout the study on fixed-flow oxygen and the auto-titrating oxygen system.
Detailed Description
Long-term oxygen therapy (LTOT) is prescribed for patients with stable severe hypoxemic respiratory failure according to specific criteria set out in different guidelines from international respiratory societies. The aim of LTOT is to maintain the resting partial pressure of oxygen (PO2) >60 mmHg or oxygen saturation (SpO2) >90%.
A number of studies have demonstrated that whilst at home, patients on LTOT experience episodes of intermittent hypoxia (SpO2 <90%) and spend significant amounts of time with SpO2 <90%. These episodes of desaturation occur most frequently during activities of daily living and may be harmful as they could lead to pulmonary hypertension, arrhythmias and ischaemic heart disease. Simply increasing the LTOT flow rate by 1 or 2 litres in one option but this exposed the patients to hyperoxaemia and the risk of hypercapnia. An another method optimising LTOT is to utilise an auto-titrating oxygen system. These system allow close control of SpO2 by automatically adjusting the flow of oxygen to match a target SpO2. At the Royal Brompton Hospital and Imperial College London, the investigators have developed our own auto-titrating oxygen system - called intelligent oxygen therapy (iO2t).
This system has been tested in patients with chronic obstructive pulmonary disease (COPD) and LTOT during a 6 minute walk test with promising results (ERS 2015).
The aim of this study is to investigate whether the intelligent oxygen therapy system can reduce intermittent hypoxia in patients on LTOT during simulated activities of daily living. Patients will be asked to a series of activities of daily living over a period of 1 hour including: washing, dressing, putting away shopping and cleaning. The patients will do these activities twice: once on their usual LTOT and once on the auto-titrating oxygen system in a cross-over design.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypoxia, COPD, Hyperoxia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
25 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Activities of daily living on iO2t
Arm Type
Experimental
Arm Description
Patients will complete simulated activities of daily living on intelligent oxygen therapy (an auto-titrating oxygen system)
Arm Title
Activities of daily living on LTOT
Arm Type
Active Comparator
Arm Description
Patients will complete activities of daily living on their usual long-term oxygen therapy.
Intervention Type
Device
Intervention Name(s)
Intelligent oxygen therapy (an auto-titrating oxygen system)
Intervention Description
This device is an auto-titrating oxygen system. The system is programmed to maintain a specific target SpO2 by automatically adjusting the oxygen flow rate. The system can deliver flow rates of 0-5 litres/minute.
Intervention Type
Device
Intervention Name(s)
Long-term oxygen therapy
Intervention Description
This is the patients usual long-term oxygen therapy
Primary Outcome Measure Information:
Title
The percentage of time spent with SpO2 <90% during the activities of daily living - 55 minutes
Time Frame
Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)
Secondary Outcome Measure Information:
Title
Mean SpO2 during the activities of daily living - 55 minutes
Time Frame
Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)
Title
Mean Heart rate during the activities of daily living - 55 minutes
Time Frame
Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)
Title
Borg score for breathlessness and fatigue at the end of activities of daily living (55 minutes)
Time Frame
At the end of activities of daily living (55 minutes)
Title
Total volume of oxygen delivered during simulated activities of daily living during the activities of daily living (55 minutes)
Time Frame
Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age >18 years
Currently on or eligible for LTOT for respiratory failure
Exclusion Criteria:
LTOT flow rate ≥4 litres per minute
Exacerbation of underlying lung disease in the past 4 weeks
Inability to understand English
Significant co-morbidities
Patients who lack capacity to consent
Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anita Simonds, FRCP
Organizational Affiliation
Royal Brompton & Harefield NHS Foundation Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royal Brompton and Harefield NHS Trust
City
London
ZIP/Postal Code
SW3 6NP
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Intelligent Oxygen Therapy During Activities of Daily Living
We'll reach out to this number within 24 hrs